Human Gene MIR500A (ENST00000385051.1) from GENCODE V44
  Description: Homo sapiens microRNA 500a (MIR500A), microRNA. (from RefSeq NR_030224)
RefSeq Summary (NR_030224): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000385051.1
Gencode Gene: ENSG00000207785.1
Transcript (Including UTRs)
   Position: hg38 chrX:50,008,431-50,008,514 Size: 84 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 09:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chrX:50,008,431-50,008,514)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerGencodeHGNCLynxMalacards
PubMed

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DI443509 - KR 1020140074997-A/130: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM004846 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FV525879 - Nucleic acid controling mast cell degranulation.
FW422188 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV533917 - WO 2011111715-A/433: Nucleic acid for controlling cell cycle.
HW368059 - JP 2012228254-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674798 - JP 2014217381-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW807835 - JP 2014534810-A/130: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ043338 - JP 2015510401-A/428: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067740 - JP 2014012020-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081964 - JP 2015514392-A/428: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408483 - JP 2015528002-A/1080: CHIRAL CONTROL.
HZ428164 - JP 2014217384-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428967 - JP 2014217385-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429770 - JP 2014217386-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430573 - JP 2014217387-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769830 - JP 2014223080-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA059224 - Sequence 726 from Patent EP2298893.
JA060027 - Sequence 726 from Patent EP2298894.
JA074350 - Sequence 726 from Patent EP2281887.
JA105487 - Sequence 726 from Patent EP2302051.
JA106827 - Sequence 726 from Patent EP2302052.
JA107630 - Sequence 726 from Patent EP2302053.
JA108433 - Sequence 726 from Patent EP2302054.
JA109236 - Sequence 726 from Patent EP2302055.
JA110039 - Sequence 726 from Patent EP2302056.
JA218667 - Sequence 726 from Patent EP2281888.
JA226818 - Sequence 726 from Patent EP2292755.
JA229673 - Sequence 726 from Patent EP2292756.
JA257944 - Sequence 726 from Patent EP2284265.
JA279224 - Sequence 726 from Patent EP2281886.
JA285110 - Sequence 726 from Patent EP2281889.
JA293163 - Sequence 726 from Patent EP2287303.
JA318349 - Sequence 726 from Patent EP2314688.
JA375408 - Sequence 726 from Patent EP2322616.
JC991160 - Sequence 726 from Patent EP2808390.
JE998709 - Sequence 29 from Patent WO2015114469.
LF404435 - JP 2015509366-A/428: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF715263 - JP 2016165292-A/726: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LG051817 - KR 1020150036642-A/1083: CHIRAL CONTROL.
LZ215763 - JP 2017518753-A/114: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ215900 - JP 2017518753-A/251: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA265114 - JP 2017502661-A/29: Covered Sequence Conversion DNA and Detection Methods.
MA353966 - JP 2018075017-A/428: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MP045606 - Sequence 428 from Patent EP3401394.
MP084276 - Sequence 428 from Patent EP3401393.
DL491178 - Novel nucleic acids.
DI443507 - KR 1020140074997-A/128: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
FW364349 - Oligonucleotides for modulating target RNA activity.
FW371739 - Human-derived nuclear acids for inhibiting HIV protein expression.
FZ414302 - WO 2011007815-A/192: A method for screening a food which promotes production of milk having immunoregulating effect.
HI965044 - Sequence 329 from Patent WO2010139812.
HI966206 - Sequence 526 from Patent WO2010139811.
HI967072 - Sequence 526 from Patent WO2010139810.
HV036096 - WO 2011027893-A/27: A method for predicting the efficacy of chronic hepatitis C treatment.
HV595258 - JP 2010539959-A/639: Micromirs.
HV821830 - JP 2011140513-A/192: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV938946 - JP 2011519579-A/1774: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HW807833 - JP 2014534810-A/128: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ043304 - JP 2015510401-A/394: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074364 - JP 2013535982-A/455: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081930 - JP 2015514392-A/394: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082946 - JP 2015513906-A/303: Stem Cell Microparticles.
HZ157815 - JP 2015130862-A/639: Micromirs.
HZ186662 - JP 2015146814-A/411: Oligonucleotides for modulating target RNA activity.
HZ436727 - JP 2015529450-A/303: Stem Cell Microparticles.
HZ482065 - JP 2015535430-A/2571: TERMINALLY MODIFIED RNA.
HZ791996 - JP 2016504050-A/3741: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401082 - Sequence 329 from Patent WO2011080318.
JA402060 - Sequence 329 from Patent WO2011080315.
JA403067 - Sequence 329 from Patent WO2011080316.
JA405698 - Sequence 329 from Patent EP2336353.
JA427083 - Sequence 416 from Patent WO2011072177.
JA429224 - Sequence 329 from Patent WO2011095623.
JA792225 - Sequence 274 from Patent WO2012089753.
JA821253 - Sequence 1774 from Patent EP2285961.
JB074961 - Sequence 221 from Patent WO2012168448.
JB136717 - Sequence 27 from Patent EP2476758.
JB149117 - Sequence 192 from Patent EP2455486.
JB175016 - Sequence 48 from Patent WO2012101219.
JB620549 - Sequence 529 from Patent WO2013063544.
JC037812 - Sequence 340 from Patent EP2643479.
JC171931 - Sequence 303 from Patent WO2013150303.
JC244680 - Sequence 300 from Patent WO2012020308.
JC514728 - Sequence 4981 from Patent WO2014113089.
JC572742 - Sequence 303 from Patent WO2014125276.
JC582430 - Sequence 303 from Patent WO2014125277.
JE954126 - Sequence 303 from Patent WO2015052526.
JE955879 - Sequence 303 from Patent WO2015052527.
LF137631 - JP 2016507550-A/303: Method of Producing Microparticles.
LF160046 - JP 2016513950-A/112: Oligomers with improved off-target profile.
LF162596 - JP 2016513095-A/303: Stem Cell Microparticles and miRNA.
LF404401 - JP 2015509366-A/394: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636315 - JP 2016519076-A/89: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953348 - JP 2016534103-A/303: Stem Cell Microparticles and miRNA.
LG005693 - KR 1020150004822-A/303: STEM CELL MICROPARTICLES.
LG053389 - KR 1020150059168-A/303: STEM CELL MICROPARTICLES.
LG134472 - KR 1020150131312-A/89: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240628 - KR 1020160035087-A/303: STEM CELL MICROPARTICLES AND MIRNA.
LP726832 - Sequence 526 from Patent EP2883966.
LP769525 - Sequence 52 from Patent EP3294910.
LP819102 - Sequence 526 from Patent EP3296406.
LP939044 - Sequence 526 from Patent EP3184651.
LP951695 - Sequence 201 from Patent WO2017157650.
LQ072316 - Sequence 2640 from Patent EP2964234.
LQ278753 - Sequence 292 from Patent WO2016066288.
LQ441214 - Sequence 221 from Patent EP3029157.
LV470713 - JP 2016534036-A/303: Stem Cell Microparticles and miRNA.
LY405323 - KR 1020160117535-A/628: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504634 - KR 1020170035932-A/23: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ215716 - JP 2017518753-A/67: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ215828 - JP 2017518753-A/179: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ234019 - JP 2017184756-A/411: Oligonucleotides for modulating target RNA activity.
LZ242915 - JP 2017525350-A/23: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260562 - JP 2017505623-A/628: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353932 - JP 2018075017-A/394: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA400865 - JP 2018515097-A/52: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA405834 - WO 2018155427-A/608: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA645817 - JP 2017113010-A/3741: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733701 - JP 2017140048-A/2571: TERMINALLY MODIFIED RNA.
MP045572 - Sequence 394 from Patent EP3401394.
MP065902 - Sequence 16 from Patent WO2018228875.
MP084242 - Sequence 394 from Patent EP3401393.
MS637998 - Sequence 115 from Patent WO2017037190.
MS834183 - Sequence 329 from Patent EP3112479.
MS944767 - Sequence 23 from Patent EP3177739.
FW364353 - Oligonucleotides for modulating target RNA activity.
FW371763 - Human-derived nuclear acids for inhibiting HIV protein expression.
HI965040 - Sequence 325 from Patent WO2010139812.
HI966100 - Sequence 420 from Patent WO2010139811.
HI966966 - Sequence 420 from Patent WO2010139810.
HV595262 - JP 2010539959-A/643: Micromirs.
HV938809 - JP 2011519579-A/1637: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HW906955 - WO 2015037656-A/170: Autophagy-regulating microRNA.
HW913353 - JP 2015504307-A/113: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HW915093 - JP 2015504655-A/51: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES.
HZ074369 - JP 2013535982-A/460: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082924 - JP 2015513906-A/281: Stem Cell Microparticles.
HZ157819 - JP 2015130862-A/643: Micromirs.
HZ186666 - JP 2015146814-A/415: Oligonucleotides for modulating target RNA activity.
HZ436705 - JP 2015529450-A/281: Stem Cell Microparticles.
HZ482073 - JP 2015535430-A/2579: TERMINALLY MODIFIED RNA.
HZ792004 - JP 2016504050-A/3749: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401078 - Sequence 325 from Patent WO2011080318.
JA402056 - Sequence 325 from Patent WO2011080315.
JA403063 - Sequence 325 from Patent WO2011080316.
JA405694 - Sequence 325 from Patent EP2336353.
JA426709 - Sequence 42 from Patent WO2011072177.
JA429220 - Sequence 325 from Patent WO2011095623.
JA791864 - Sequence 266 from Patent WO2012089772.
JA821116 - Sequence 1637 from Patent EP2285961.
JB022666 - Sequence 508 from Patent WO2013026685.
JB050117 - Sequence 204 from Patent WO2013020926.
JB074944 - Sequence 204 from Patent WO2012168448.
JB406743 - Sequence 69 from Patent WO2012072685.
JB620554 - Sequence 534 from Patent WO2013063544.
JB751169 - Sequence 51 from Patent WO2013087907.
JB778734 - Sequence 113 from Patent WO2013078283.
JC011145 - Sequence 10 from Patent EP2639314.
JC037815 - Sequence 343 from Patent EP2643479.
JC171909 - Sequence 281 from Patent WO2013150303.
JC244683 - Sequence 303 from Patent WO2012020308.
JC514736 - Sequence 4989 from Patent WO2014113089.
JC572720 - Sequence 281 from Patent WO2014125276.
JC582408 - Sequence 281 from Patent WO2014125277.
JE954104 - Sequence 281 from Patent WO2015052526.
JE955857 - Sequence 281 from Patent WO2015052527.
LF137609 - JP 2016507550-A/281: Method of Producing Microparticles.
LF161000 - JP 2016513950-A/1066: Oligomers with improved off-target profile.
LF162574 - JP 2016513095-A/281: Stem Cell Microparticles and miRNA.
LF953326 - JP 2016534103-A/281: Stem Cell Microparticles and miRNA.
LG005671 - KR 1020150004822-A/281: STEM CELL MICROPARTICLES.
LG053367 - KR 1020150059168-A/281: STEM CELL MICROPARTICLES.
LG240606 - KR 1020160035087-A/281: STEM CELL MICROPARTICLES AND MIRNA.
LP726726 - Sequence 420 from Patent EP2883966.
LP818996 - Sequence 420 from Patent EP3296406.
LP838689 - Sequence 14 from Patent WO2017186719.
LP938938 - Sequence 420 from Patent EP3184651.
LP951627 - Sequence 133 from Patent WO2017157650.
LQ072324 - Sequence 2648 from Patent EP2964234.
LQ422063 - Sequence 1 from Patent EP3026121.
LQ441197 - Sequence 204 from Patent EP3029157.
LQ472193 - Sequence 39 from Patent WO2016115609.
LQ565049 - Sequence 74 from Patent WO2016139092.
LV470691 - JP 2016534036-A/281: Stem Cell Microparticles and miRNA.
LY405327 - KR 1020160117535-A/632: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504796 - KR 1020170035932-A/185: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ234023 - JP 2017184756-A/415: Oligonucleotides for modulating target RNA activity.
LZ243077 - JP 2017525350-A/185: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260566 - JP 2017505623-A/632: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA405661 - WO 2018155427-A/435: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA645825 - JP 2017113010-A/3749: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733709 - JP 2017140048-A/2579: TERMINALLY MODIFIED RNA.
MA765531 - JP 2017514519-A/97: Small ncRNAs as biomarkers.
MA765593 - JP 2017514519-A/159: Small ncRNAs as biomarkers.
MS638022 - Sequence 139 from Patent WO2017037190.
MS834179 - Sequence 325 from Patent EP3112479.
MS902035 - Sequence 508 from Patent EP3156505.
MS944929 - Sequence 185 from Patent EP3177739.
AY882306 - Homo sapiens microRNA HSA-MIR-RG-75, complete sequence.
CS548481 - Sequence 1511 from Patent EP1777301.
FV524328 - Nucleic acid controling mast cell degranulation.
FW312238 - DETECTING NUCLEIC ACIDS.
FW364350 - Oligonucleotides for modulating target RNA activity.
FW371725 - Human-derived nuclear acids for inhibiting HIV protein expression.
FW371744 - Human-derived nuclear acids for inhibiting HIV protein expression.
FW371771 - Human-derived nuclear acids for inhibiting HIV protein expression.
HI965043 - Sequence 328 from Patent WO2010139812.
HI965991 - Sequence 311 from Patent WO2010139811.
HI966857 - Sequence 311 from Patent WO2010139810.
HV533508 - WO 2011111715-A/24: Nucleic acid for controlling cell cycle.
HV555504 - JP 2012016294-A/20: Composition or kit for determining sensitivity to auxiliary chemotherapy of stomach cancer.
HV595259 - JP 2010539959-A/640: Micromirs.
HV938947 - JP 2011519579-A/1775: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HZ074365 - JP 2013535982-A/456: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082687 - JP 2015513906-A/44: Stem Cell Microparticles.
HZ157816 - JP 2015130862-A/640: Micromirs.
HZ186663 - JP 2015146814-A/412: Oligonucleotides for modulating target RNA activity.
HZ436468 - JP 2015529450-A/44: Stem Cell Microparticles.
HZ482064 - JP 2015535430-A/2570: TERMINALLY MODIFIED RNA.
HZ791995 - JP 2016504050-A/3740: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401081 - Sequence 328 from Patent WO2011080318.
JA402059 - Sequence 328 from Patent WO2011080315.
JA403066 - Sequence 328 from Patent WO2011080316.
JA405697 - Sequence 328 from Patent EP2336353.
JA429223 - Sequence 328 from Patent WO2011095623.
JA660668 - Sequence 122 from Patent WO2011131354.
JA784092 - Sequence 6 from Patent EP2460005.
JA821254 - Sequence 1775 from Patent EP2285961.
JB049986 - Sequence 73 from Patent WO2013020926.
JB074953 - Sequence 213 from Patent WO2012168448.
JB620550 - Sequence 530 from Patent WO2013063544.
JC037813 - Sequence 341 from Patent EP2643479.
JC171672 - Sequence 44 from Patent WO2013150303.
JC244681 - Sequence 301 from Patent WO2012020308.
JC334431 - Sequence 349 from Patent EP2487240.
JC514727 - Sequence 4980 from Patent WO2014113089.
JC572483 - Sequence 44 from Patent WO2014125276.
JC582171 - Sequence 44 from Patent WO2014125277.
JE953867 - Sequence 44 from Patent WO2015052526.
JE955620 - Sequence 44 from Patent WO2015052527.
JE978677 - Sequence 122 from Patent EP2865765.
LF137372 - JP 2016507550-A/44: Method of Producing Microparticles.
LF160963 - JP 2016513950-A/1029: Oligomers with improved off-target profile.
LF162337 - JP 2016513095-A/44: Stem Cell Microparticles and miRNA.
LF953089 - JP 2016534103-A/44: Stem Cell Microparticles and miRNA.
LG005434 - KR 1020150004822-A/44: STEM CELL MICROPARTICLES.
LG053130 - KR 1020150059168-A/44: STEM CELL MICROPARTICLES.
LG240369 - KR 1020160035087-A/44: STEM CELL MICROPARTICLES AND MIRNA.
LP726617 - Sequence 311 from Patent EP2883966.
LP818887 - Sequence 311 from Patent EP3296406.
LP938829 - Sequence 311 from Patent EP3184651.
LP951615 - Sequence 121 from Patent WO2017157650.
LP997099 - Sequence 48 from Patent WO2017136662.
LQ072315 - Sequence 2639 from Patent EP2964234.
LQ278490 - Sequence 29 from Patent WO2016066288.
LQ441206 - Sequence 213 from Patent EP3029157.
LV470454 - JP 2016534036-A/44: Stem Cell Microparticles and miRNA.
LY405324 - KR 1020160117535-A/629: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504726 - KR 1020170035932-A/115: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ234020 - JP 2017184756-A/412: Oligonucleotides for modulating target RNA activity.
LZ243007 - JP 2017525350-A/115: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260563 - JP 2017505623-A/629: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA405658 - WO 2018155427-A/432: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA645816 - JP 2017113010-A/3740: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733700 - JP 2017140048-A/2570: TERMINALLY MODIFIED RNA.
MP073601 - Sequence 48 from Patent WO2018236590.
MP080374 - Sequence 48 from Patent WO2018236589.
MS834182 - Sequence 328 from Patent EP3112479.
MS944859 - Sequence 115 from Patent EP3177739.
MA802870 - JP 2018183181-A/3741: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802878 - JP 2018183181-A/3749: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802869 - JP 2018183181-A/3740: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129403 - Sequence 303 from Patent EP3470073.
MP162326 - Sequence 303 from Patent WO2019069093.
MP168092 - Sequence 99 from Patent EP3469101.
MP129381 - Sequence 281 from Patent EP3470073.
MP162304 - Sequence 281 from Patent WO2019069093.
MP168094 - Sequence 101 from Patent EP3469101.
MP129144 - Sequence 44 from Patent EP3470073.
MP162067 - Sequence 44 from Patent WO2019069093.
MP168091 - Sequence 98 from Patent EP3469101.
MA867017 - JP 2018537983-A/36: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA867022 - JP 2018537983-A/41: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA867068 - JP 2018537983-A/87: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA866994 - JP 2018537983-A/13: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA866999 - JP 2018537983-A/18: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA867045 - JP 2018537983-A/64: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MB017942 - JP 2018506997-A/74: SIGNATURE OF HEALTH.
MP241469 - Sequence 25 from Patent EP3506912.
MP241468 - Sequence 24 from Patent EP3506912.
MB481519 - JP 2019528758-A/99: Methods And Compositions For Prostate Cancer Diagnosis And Treatment.
MB481521 - JP 2019528758-A/101: Methods And Compositions For Prostate Cancer Diagnosis And Treatment.
MB481518 - JP 2019528758-A/98: Methods And Compositions For Prostate Cancer Diagnosis And Treatment.
MP395060 - Sequence 158 from Patent EP3565903.
MP395058 - Sequence 156 from Patent EP3565903.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_030224, uc022bwg.1
UCSC ID: ENST00000385051.1
RefSeq Accession: NR_030224

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.